Market Exclusive

Analyst Activity – Cantor Fitzgerald Reiterates Overweight on Bellicum Pharmaceuticals (NASDAQ:BLCM)

Analyst Ratings For Bellicum Pharmaceuticals (NASDAQ:BLCM)

Today, Cantor Fitzgerald reiterated its Overweight rating on Bellicum Pharmaceuticals (NASDAQ:BLCM) with a price target of $10.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Bellicum Pharmaceuticals (NASDAQ:BLCM)
Bellicum Pharmaceuticals (NASDAQ:BLCM) has insider ownership of 18.77% and institutional ownership of 55.24%.

Recent Trading Activity for Bellicum Pharmaceuticals (NASDAQ:BLCM)
Shares of Bellicum Pharmaceuticals closed the previous trading session at with 5.019999980926514 shares trading hands.

Exit mobile version